Caggiano, Anthony O.,Ganguly, Anindita,Iaci, Jennifer,Parry, Tom
申请号：
AU2018264093
公开号：
AU2018264093A1
申请日:
2018.11.15
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018264093A120181206.pdf#####ABSTRACT The invention relates to treatment and prevention of heart failure in a mammal. The invention provides a dosing regimen whereby the therapeutic benefits conferred by administration of peptide comprising an epidermal growth factor-like domain, e.g., a neuregulin such as glial growth factor 2 (GGF2) or a functional fragment thereof, are maintained and/or enhanced, while concomitantly minimizing any potential side effects.
